“…Currently 3D printing offers a promising approach for customizing patient-specific precise scaffold structures in clinical applications. However, printing feasibility, physicochemical properties, and biological features remain significant challenges for 3D printed scaffolds’ in-ground realization toward bone regeneration. − This is due to the limitations in terms of a currently unavailable suitable polymer based bioink, low affinity of adherence of cells, and inadequate osteogenic surface bioactivity of the fabricated scaffolds. , Segmented polyurethane or polyurethane–urea (SPU) remains as a polymer matrix of choice owing to its chemical versatility, physicochemical properties, and suitable degradability promoting its application in varying biomedical fields such as vascular grafts, drug carrier systems, biosensors, or muscle tissue regeneration. ,− Its tunable physicomechanical properties by changing the percentage of constituent hard segments (HSs)–soft segments (SSs) and the nonacidic environment of the degraded product make it a promising substitute in osteoconductive applications over other polymers . Along with the polymer matrix osteoconductive nanomaterial, nanohydroxyapatite (nHA) or decorated nHA is widely used in bone graft substitutes owing to the fact that its superior biocompatibility, high aspect ratio, chemical structure, and Ca/P ratio (Ca/P ratio 1.67) mimic the apatite of the human skeleton .…”